Loading organizations...
MIG Capital is a Munich-based venture capital firm, investing in early-stage Life Science and Deep Tech companies throughout Europe. The firm provides strategic capital and operational guidance, translating scientific breakthroughs into market-ready solutions. It closely partners with entrepreneurs, leveraging a multidisciplinary team to nurture innovative ventures.
Founded in 2004, MIG Capital originated from the insight that European scientific research held untapped commercial potential, particularly in areas requiring significant capital and long-term development. Founders with diverse science, engineering, and finance backgrounds identified a critical need for patient capital and expert mentorship to bridge academic innovation with market success.
The firm primarily supports ambitious startup founders, offering resources to scale deep technology and life science companies. MIG Capital's vision centers on cultivating a robust innovation ecosystem by actively backing disruptive technologies poised to address critical global challenges. It builds enduring businesses by empowering visionary entrepreneurs from foundational stages.
MIG Capital has more than 26 tracked investments across 21 companies. The latest tracked deal is $20.0M Other Equity in GlassPoint Solar in January 2026.